Literature DB >> 19960569

Effect of ONO-4057 and tacrolimus on ischemia-reperfusion injury of the liver.

Takayuki Takeichi1, Shinji Uemoto, Sachiko Minamiguchi, Izumi Takeyoshi, Yukihiro Inomata, Koichi Tanaka, Eiji Kobayashi.   

Abstract

AIM: To investigate the effects of a novel Leukotriene B(4) receptor antagonist and/or tacrolimus on ischemia-reperfusion in a rat liver model.
METHODS: Male Lewis rats were pretreated with ONO-4057 (100 mg/kg) and/or tacrolimus (1 mg/kg) orally, and divided into four experimental groups; group 1 (control), group 2 (ONO-4057), group 3 (tacrolimus), group 4 (ONO-4057 + tacrolimus).
RESULTS: There was a tendency for long survival in the groups treated with tacrolimus alone and ONO-4057 plus tacrolimus. Post-reperfusion serum aspartate aminotransferase levels decreased more significantly in ONO-4057 plus tacrolimus group (P < 0.01), than in the tacrolimus alone group (P < 0.05), compared to controls.
CONCLUSION: This study demonstrated that pretreatment with ONO-4057 in combination with tacrolimus produced additive effects in a rat model of liver ischemia-reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19960569      PMCID: PMC2789225          DOI: 10.3748/wjg.15.5712

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  20 in total

1.  ONO-LB-457: a novel and orally active leukotriene B4 receptor antagonist.

Authors:  K Kishikawa; N Matsunaga; T Maruyama; R Seo; M Toda; T Miyamoto; A Kawasaki
Journal:  Adv Prostaglandin Thromboxane Leukot Res       Date:  1991

2.  Tacrolimus (FK506) down-regulates free radical tissue levels, serum cytokines, and neutrophil infiltration after severe liver ischemia.

Authors:  F J Garcia-Criado; J M Palma-Vargas; J J Valdunciel-Garcia; A H Toledo; K Misawa; A Gomez-Alonso; L H Toledo-Pereyra
Journal:  Transplantation       Date:  1997-08-27       Impact factor: 4.939

3.  The immunosuppressive effects of a leukotriene B4 receptor antagonist on liver allotransplantation in rats.

Authors:  T Ii; R Izumi; K Shimizu
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

4.  Sulfo-Lewis(x) diminishes neutrophil infiltration and free radicals with minimal effect on serum cytokines after liver ischemia and reperfusion.

Authors:  F J Garcia-Criado; J M Palma-Vargas; J J Valdunciel-Garcia; A Gomez-Alonso; O Srivastava; A Ezrin; M B Anderson; L H Toledo-Pereyra
Journal:  J Surg Res       Date:  1997-07-01       Impact factor: 2.192

5.  Protective effect of FK506 on ischemia/reperfusion-induced myocardial damage in canine heart.

Authors:  Y Nishinaka; S Sugiyama; M Yokota; H Saito; T Ozawa
Journal:  J Cardiovasc Pharmacol       Date:  1993-03       Impact factor: 3.105

6.  Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine.

Authors:  S Suzuki; L H Toledo-Pereyra; F J Rodriguez; D Cejalvo
Journal:  Transplantation       Date:  1993-06       Impact factor: 4.939

7.  ONO-4057, a novel, orally active leukotriene B4 antagonist: effects on LTB4-induced neutrophil functions.

Authors:  K Kishikawa; N Tateishi; T Maruyama; R Seo; M Toda; T Miyamoto
Journal:  Prostaglandins       Date:  1992-10

8.  Ischemia-reperfusion-induced mucosal dysfunction: role of neutrophils.

Authors:  H Kurtel; K Fujimoto; B J Zimmerman; D N Granger; P Tso
Journal:  Am J Physiol       Date:  1991-09

9.  The protective effect of FK506 pretreatment against renal ischemia/reperfusion injury in rats.

Authors:  M Sakr; G Zetti; C McClain; J Gavaler; M Nalesnik; S Todo; T Starzl; D Van Thiel
Journal:  Transplantation       Date:  1992-05       Impact factor: 4.939

10.  Role of leukotriene B4 in the pathogenesis of hepatic ischemia-reperfusion injury in the rat.

Authors:  H Hughes; A Farhood; H Jaeschke
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1992-02       Impact factor: 4.006

View more
  1 in total

1.  Protocol TOP-Study (tacrolimus organ perfusion): a prospective randomized multicenter trial to reduce ischemia reperfusion injury in transplantation of marginal liver grafts with an ex vivo tacrolimus perfusion.

Authors:  Sebastian Pratschke; Michael Eder; Michael Heise; Silvio Nadalin; Andreas Pascher; Peter Schemmer; Marcus N Scherer; Frank Ulrich; Heiner Wolters; Karl-Walter Jauch; Dirk Wöhling; Martin K Angele
Journal:  Transplant Res       Date:  2013-03-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.